DTaP-poliovirus vaccine adult (GlaxoSmithKline)
成人DTaP-脊髓灰质炎病毒疫苗
Report date: 2023/04/12 17:24:07
Base Information
Drug NameDTaP-poliovirus vaccine adult (GlaxoSmithKline)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications +[4]
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2008/02/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksWikipedia